Benefits of long-term routine lab drug toxicity monitoring unclear in rheumatoid arthritis
For patients with rheumatoid arthritis (RA) using disease-modifying antirheumatic drugs (DMARDs), long-term routine laboratory toxicity monitoring (lt-RLTM) indicates that most very abnormal laboratory results are already ...
Aug 26, 2025
0
15









